Our division has trained more than 200 residents and more than 70 fellows, including many from Korea, Turkey, Japan, Poland, Colombia, and Brazil.
Clinical trials of investigational drugs for Lambert-Eaton myasthenic syndrome (LEMS), CIDP, and myasthenia gravis are ongoing, and treatment with intravenous immunoglobulin (IVIG), plasmapheresis, and other therapies are available through our department. Research is in the clinical field with emphasis on new techniques of electrodiagnostic testing.
Contact UsFor general questions about the division, contact:
UAB Division of Neuromuscular Disease
1720 7th Avenue South, Sparks Center 240
Birmingham, Alabama 35294
For patient appointments, contact:
The Kirklin Clinic
For urgent physician referrals, contact
P: 1.800.UAB.MIST (822.6478)